Lopinavir/Ritonavir vs. Nelfinavir in Treatment-Naive Patients
Lopinavir/ritonavir was associated with a higher likelihood of virologic control than nelfinavir, and treatment failure was associated with the emergence of protease mutations in patients receiving nelfinavir but not in those receiving lopinavir-ritonavir.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)